Dedicated to improving the lives of people with diabetes throughout the world by empowering healthcare professionals with training, education and information on diabetes and cardiovascular
disease.

Our Mission >>

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Educate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collaborate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transform

 

UPCOMING PROGRAMS


Cardiorenal syndrome (CRS) in people with type 2 diabetes mellitus illustrates the bidirectional link between the heart and the kidneys, with acute or chronic dysfunction of one organ adversely impacting the function of the other. The cardiovascular and renoprotective benefits evidenced with sodium-glucose transporter-2 (SGLT-2) inhibitors make them a potential choice in the management of CRS.

Join the Worldwide CardioDiabetes on-demand symposium, “Practical Applications in Managing Patients with CardioRenal Disease: New SBLT-2 Study Data”, to learn more about the results of recent studies and how to apply this knowledge to your daily practice. It will be available during the upcoming 76th Annual Brazilian Congress of Cardiology and thereafter on this website. You can register via https://congressosbc.associatec.com.br to view the program during the congress dates and check back here thereafter for open, on-demand access.

Click here to view the symposium faculty and agenda in full detail.



On Friday, December 10, 2021, Worldwide Diabetes will present the live virtual symposium “Topical Oxygen Therapy for Diabetic Foot Ulcers: New Evidence” in partnership with IDF Virtual Congress 2021 (Complications – COVID-19). This program will focus on the advancement in the treatment of diabetic foot ulcers and will present evidence for new therapies that lead to optimal results for patients.

In order to participate in this virtual symposium, please be sure to register for the overall IDF Virtual Congress. To register, please visit https://idf2021.org/registration/. Upon the conclusion of the Congress, the symposium will be available on-demand via the Congress website as well as on this site.

Click here to view the symposium faculty and agenda in full detail.



During the upcoming IDF Virtual Congress 2021 (Complications – COVID-19), Worldwide Diabetes will present the virtual satellite symposium “Modern Management of Refractory Painful Diabetic Neuropathy Including High-Frequency Stimulation.” This symposium will be held live on Wednesday, December 8, 2021. It will provide an overview of the problems associated with diabetic neuropathy and evaluate the evidence behind various management strategies, including newer technologies, that are part of the armamentarium that health care professionals have available in treating their patients.

To participate in this virtual symposium, please be sure to register for the overall IDF Virtual Congress. Visit https://idf2021.org/registration/ to register. Upon the conclusion of the congress, IDF will post the satellite symposium as part of its on-demand viewing and it will be posted on this website as well.

Click here to view the symposium faculty and agenda in more detail.



On Monday, December 6, 2021, Worldwide Diabetes will be sponsoring a virtual satellite symposium in partnership with IDF Virtual Congress 2021 (Complications – COVID-19). The program, titled “Reaching Therapeutic Goals in Type 2 Diabetes: What We Have Learned”, will include three presentations that focus on the evolution of the use of insulin in managing type 2 diabetes, including what formulations are on the horizon.

To participate in this virtual symposium, please be sure to register for the overall IDF Virtual Congress. Visit https://idf2021.org/registration/ to register. Upon the conclusion of the congress, IDF will post the satellite symposium as part of its on-demand viewing and it will be posted on this website as well.

Click here to view the symposium agenda.


ON DEMAND PROGRAMS


The virtual symposium “Reaching Therapeutic Goals in Type 2 Diabetes: New Options” was held in conjunction with the 55th Congress of the German Diabetes Society (DDG) on May 13, 2021. The 90-minute program featured Drs. Petra-Maria Schumm-Draeger (Munich) and Andrew J.M. Boulton (Manchester) as co-chairs, with vibrant presentations by Drs. Boulton, Brian Frier (Edinburgh), Paolo Pozzilli (Rome), and Oliver Schnell (Munich-Neuherberg). All presentations are available on demand for viewing per the links below. In addition, copies of the slides are available upon return of a short survey.

Click here to access the presentation videos.

Click here to access the survey.


“Reaching Therapeutic Goals in Type 2 Diabetes” was held as a live webinar on January 27, 2021 and is now available on-demand. This webinar features prominent international speakers from England, India, and Kuwait, and a lively question and answer session. We invite you to participate in this virtual program as well as read the live webinar blog posts written by the speakers. The posts contain current information about proven approaches to preventing hypoglycemia, fixed dose combination treatments in managing type 2 diabetes, the impact of uncontrolled diabetes on overall cardiovascular health, the challenges in treating the global burden of diabetes, and how to optimize type 2 diabetes treatment results amidst the COVID-19 pandemic.    

Click here to review the Recorded Program.


Worldwide Diabetes held a live webinar on November 28, 2020 in conjunction with the 34th Congresso Brasileiro de Endocrinolgia e Metabologia (a virtual event). “Advancing Strategies in the Management of Type 2 Diabetes” featured speakers from Belgium, Brazil, England, and the United States and included presentations on preventing hypoglycemia, new uses of insulin, the psychological aspects of patient adherence, and how recent results of cardiovascular outcomes trials point to new treatment options. The webinar is now available on demand.

Click here to view the program.


DIABETES UPDATE FROM OUR FELLOW
Pei Lin Chan, MBBS (IMU), MRCP (UK)

In her latest column, Dr. Pei Lin Chan focuses on the rise in end-stage renal disease among patients with type 2 diabetes. She discusses several recent clinical studies that have shown delays and reductions in renal complications as well as cardiorenal protection. Please take a moment to read her column and check back here for her continuing editorial contributions.   

Click here to read the column.

Click here for Dr. Chan’s previous columns.

 

 

FEATURED PROGRAM

Worldwide Cardio Diabetes held a virtual symposium during the recent 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease and it is now available on demand. “Diabetes and CardioRenal Disease: Can We Reduce the Impact of this Deadly Combination” features presentations by Drs. Andrew Boulton, George Bakris, Martin Rutter, and Philip Home, delving into the important topics of the kidney and cardiovascular risk, treating heart failure, and improving outcomes in diabetes beyond glucose control therapies.

Click here to view the program.